Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China · Delayed Price · Currency is CNY 30.73
+1.56 (5.35%)
Aug 4, 2026, 3:04 PM CST
SHE:300878 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 181.62 | 137.42 | 253.96 | 330.16 | 162.74 | 280.8 |
Trading Asset Securities | 10.28 | 10.02 | - | 245.56 | - | - |
Cash & Short-Term Investments | 191.9 | 147.44 | 253.96 | 575.73 | 162.74 | 280.8 |
Cash Growth | -27.63% | -41.95% | -55.89% | 253.77% | -42.04% | -52.83% |
Accounts Receivable | 148.3 | 138.72 | 165.71 | 264.97 | 333.89 | 409.9 |
Other Receivables | 11.83 | 11.64 | 52.15 | 29.1 | 366.31 | 2.76 |
Receivables | 160.13 | 150.36 | 217.87 | 294.07 | 700.2 | 412.65 |
Inventory | 54.82 | 60.87 | 118.32 | 153.78 | 116.78 | 129.49 |
Other Current Assets | 23.58 | 24.58 | 26.33 | 28.16 | 54.27 | 47.15 |
Total Current Assets | 430.44 | 383.25 | 616.48 | 1,052 | 1,034 | 870.09 |
Property, Plant & Equipment | 752.01 | 759.09 | 853.66 | 857.39 | 761.5 | 706.09 |
Long-Term Investments | - | 12.5 | 25 | 26.55 | 25 | 19.96 |
Goodwill | - | - | 10.97 | 27.08 | 27.22 | 17.62 |
Other Intangible Assets | 29.97 | 30.09 | 33.59 | 35.67 | 37.56 | 39.31 |
Long-Term Deferred Tax Assets | 32.51 | 35.23 | 54.67 | 27.07 | 16.63 | 24.59 |
Long-Term Deferred Charges | 11.27 | 12.01 | 2.51 | 5.07 | 6.11 | 7.03 |
Other Long-Term Assets | 31.28 | 19.06 | 55.44 | 31.17 | 6.52 | 8.62 |
Total Assets | 1,287 | 1,251 | 1,652 | 2,062 | 1,915 | 1,693 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 26.63 | 47.01 | 78.85 | 101.12 | 95.75 | 97.26 |
Accrued Expenses | 4.26 | 44.98 | 44.74 | 52.09 | 24.61 | 53.2 |
Short-Term Debt | 138.35 | 63.34 | 10.01 | 261.9 | 257.25 | 50.06 |
Current Portion of Long-Term Debt | 9.93 | 8.89 | 88.21 | - | - | - |
Current Portion of Leases | - | 1.04 | 2.55 | 10.21 | 11.76 | 12.29 |
Current Income Taxes Payable | 17.36 | 0 | 0.14 | 0.26 | 2.33 | 6.09 |
Current Unearned Revenue | 5.56 | 9.51 | 11.18 | 14.7 | 15.79 | 8.39 |
Other Current Liabilities | 19.19 | 10.65 | 4.7 | 5.28 | 5.58 | 5.12 |
Total Current Liabilities | 221.27 | 185.42 | 240.38 | 445.55 | 413.07 | 232.4 |
Long-Term Debt | 89.96 | 89.95 | 186.62 | 149.95 | 33.39 | - |
Long-Term Leases | 1.34 | 1.71 | 5.18 | 13.18 | 16.71 | 19.99 |
Long-Term Unearned Revenue | 40.97 | 42.03 | 38.92 | 42.83 | 32.65 | 25.01 |
Long-Term Deferred Tax Liabilities | 8.37 | 8.38 | 7.4 | 2.03 | 7.67 | 6.89 |
Total Liabilities | 361.92 | 327.5 | 478.5 | 653.55 | 503.49 | 284.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 144.79 | 144.79 | 144.79 | 144.79 | 144.79 | 80.44 |
Additional Paid-In Capital | 680.77 | 680.77 | 680.77 | 680.77 | 680.77 | 745.12 |
Retained Earnings | 136.62 | 134.88 | 382.11 | 565.05 | 572.29 | 571.76 |
Treasury Stock | -50 | -50 | -50 | - | - | - |
Total Common Equity | 912.18 | 910.44 | 1,158 | 1,391 | 1,398 | 1,397 |
Minority Interest | 13.37 | 13.29 | 16.16 | 17.6 | 13.2 | 11.71 |
Shareholders' Equity | 925.55 | 923.73 | 1,174 | 1,408 | 1,411 | 1,409 |
Total Liabilities & Equity | 1,287 | 1,251 | 1,652 | 2,062 | 1,915 | 1,693 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 239.58 | 164.94 | 292.57 | 435.24 | 319.1 | 82.34 |
Net Cash (Debt) | -47.68 | -17.5 | -38.61 | 140.48 | -156.36 | 198.46 |
Net Cash Growth | - | - | - | - | - | -65.81% |
Net Cash Per Share | -0.33 | -0.12 | -0.27 | 0.94 | -1.09 | 1.38 |
Filing Date Shares Outstanding | 142.05 | 142.05 | 142.05 | 144.79 | 144.79 | 144.79 |
Total Common Shares Outstanding | 142.05 | 142.05 | 142.05 | 144.79 | 144.79 | 144.79 |
Working Capital | 209.17 | 197.83 | 376.1 | 606.19 | 620.93 | 637.69 |
Book Value Per Share | 6.42 | 6.41 | 8.15 | 9.60 | 9.65 | 9.65 |
Tangible Book Value | 882.21 | 880.35 | 1,113 | 1,328 | 1,333 | 1,340 |
Tangible Book Value Per Share | 6.21 | 6.20 | 7.84 | 9.17 | 9.21 | 9.26 |
Buildings | - | 720.24 | 734.33 | 408.8 | 344.26 | 239.09 |
Machinery | - | 250.17 | 258.81 | 307.22 | 286.89 | 162.96 |
Construction In Progress | - | 40.21 | 55.1 | 270.43 | 225.09 | 366.57 |